JY
ORGO icon

Jeff Yass’s Organogenesis Holdings ORGO Stock Holding History

Jeff Yass’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39K Sell
16,064
-12,243
-43% -$29.9K ﹤0.01% 12910
2026
Q1 		$67.1K Sell
28,307
-39,002
-58% -$135K ﹤0.01% 12533
2025
Q4 		$349K Buy
67,309
+51,423
+324% +$249K ﹤0.01% 9592
2025
Q3 		$67K Sell
15,886
-109,124
-87% -$507K ﹤0.01% 11756
2025
Q2 		$458K Buy
125,010
+6,652
+6% +$24.8K ﹤0.01% 9381
2025
Q1 		$511K Buy
118,358
+69,639
+143% +$281K ﹤0.01% 8859
2024
Q4 		$156K Buy
48,719
+32,339
+197% +$109K ﹤0.01% 10982
2024
Q3 		$46.8K Buy
+16,380
New +$45.9K ﹤0.01% 11405
2024
Q2 		– Sell
-11,072
Closed -$29.7K – 12901
2024
Q1 		$31.4K Sell
11,072
-30,295
-73% -$103K ﹤0.01% 11703
2023
Q4 		$169K Sell
41,367
-343,643
-89% -$962K ﹤0.01% 10853
2023
Q3 		$1.22M Sell
385,010
-297,785
-44% -$946K ﹤0.01% 6180
2023
Q2 		$2.27M Sell
682,795
-75,051
-10% -$222K ﹤0.01% 4899
2023
Q1 		$1.61M Buy
+757,846
New +$1.87M ﹤0.01% 5623
2022
Q4 		– Sell
-26,554
Closed -$77.5K – 13326
2022
Q3 		$86K Sell
26,554
-34,531
-57% -$156K ﹤0.01% 11816
2022
Q2 		$298K Sell
61,085
-19,052
-24% -$117K ﹤0.01% 9579
2022
Q1 		$611K Sell
80,137
-60,466
-43% -$468K ﹤0.01% 8439
2021
Q4 		$1.3M Buy
140,603
+63,690
+83% +$676K ﹤0.01% 6569
2021
Q3 		$1.09M Sell
76,913
-81,075
-51% -$1.26M ﹤0.01% 7317
2021
Q2 		$2.63M Buy
157,988
+131,906
+506% +$2.46M ﹤0.01% 5321
2021
Q1 		$475K Buy
+26,082
New +$353K ﹤0.01% 9604
2019
Q2 		– Sell
-11,690
Closed -$88K – 10659
2019
Q1 		$88K Buy
+11,690
New +$233K ﹤0.01% 8298

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jeff Yass's ORGO Position: Q2 2026 in Review

Jeff Yass reduced its Organogenesis Holdings (ORGO) stake by 43% in Q2 2026, selling an estimated $29.9K and leaving 16,064 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #12910.

Jeff Yass first reported a position in ORGO in Q1 2019 and has held it in 21 quarters since. The position peaked at $2.63M in Q2 2021. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Jeff Yass held 16,064 shares of Organogenesis Holdings worth $39K as of Q2 2026.
  • Jeff Yass sold 12,243 Organogenesis Holdings shares in Q2 2026, an estimated $29.9K.
  • Organogenesis Holdings made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12910 holding.
  • Jeff Yass first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 21 quarters since.
  • Jeff Yass's Organogenesis Holdings position peaked at $2.63M in Q2 2021.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.